2023-505340-19-00已完成1 期
A Drug Absorption Study of MK-3475A in Participants with Solid Tumors
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 34
- 试验地点
- 5
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Omobolaji Akala
Scientific
Merck Sharp & Dohme LLC
研究点 (5)
Loading locations...
相似试验
招募中
4 期
A Study to Evaluate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of Xdivane versus Opdivo® in Patients with Resected MelanomaMelanoma2025-522307-14-00Intas Pharmaceuticals Limited19
进行中（未招募）
不适用
A Bioavailability Study of MK-3475A in Participants with Solid TumorsjRCT2031220507MSD K.K.96
已完成
1 期
A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)NCT07266818Merck Sharp & Dohme LLC30
已完成
1 期
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR445710) in Subjects With Metastatic or Locally Advanced Solid TumorsCancer2022-503080-15-00Kadmon Corporation LLC30
招募中
1 期
A clinical study of MK-6916 in healthy people (MK-6916-006)2025-521487-36-00Merck Sharp & Dohme LLC40